Delivery Order SPE2DB25D7067-SPE2DB25FSUSU

Award Date 3/13/25
Potential Completion Date 3/14/25
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,281.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of SEREVENT DISKUS 50 MCG 60S, a medication used to treat respiratory conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of SEREVENT DISKUS 50 MCG 60S pharmaceutical product. The contract has a ceiling value of $7,647.62 and an ultimate completion date of November 22, 2024. It is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,733.22 firm fixed-price contract is for the delivery of SEREVENT DISKUS 50 MCG 60S pharmaceutical products. The contract is not designated as a set-aside and represents an indefinite delivery contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This contract award to Amerisourcebergen Drug Corp. is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at $999,999,999. The award is for the pharmaceutical product SEREVENT DISKUS 50 MCG 60S, a medication used for respiratory conditions. The contract has no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor providing this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,000.96 firm fixed-price delivery order is for SEREVENT DISKUS 50 MCG 60S, a respiratory medication. The contract has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,746.24 firm fixed price delivery order is for the supply of SEREVENT DISKUS 50 MCG 60S, a respiratory medication. The award has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,707.54 delivery order contract is for the supply of SEREVENT DISKUS 50 MCG 60S, a pharmaceutical product. The contract has a completion date of March 10, 2025 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SEREVENT DISKUS 50 MCG 60S medication. The $3,371.52 firm fixed-price contract has a completion date of February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,721.72, is a Firm Fixed Price Delivery Order for the supply of SEREVENT DISKUS 50 MCG 60S, a pharmaceutical product. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. The contract does not have a set-aside designation, indicating it was an open...
This federal contract award of $2,060.21 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of SEREVENT DISKUS 50 MCG 60S, a pharmaceutical product, with a completion date of January 30, 2025. The contract award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB25D7067
    Indefinite Delivery Contract
  • SPE2DB25D7067-SPE2DB25FSUSU
    Delivery Order

This federal contract award, valued at $6,957.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SEREVENT DISKUS 50 MCG 60S, a pharmaceutical product, with a completion date of March 14, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract award did not have a set-aside designation, indicating open competition.

Generated 6/12/25, 9:54 AM